Skip to main content
HANDLING GUIDE

Laboratory Storage Guide

General-purpose storage practice for lyophilised and reconstituted peptide reference standards in a laboratory setting.

QUICK ANSWER
TL;DR

Quick answer

Lyophilised peptide reference standards are typically stored at −20 °C, desiccated and protected from light. Reconstituted stocks are stored short-term at 2–8 °C and long-term as single-use aliquots at −20 °C to minimise freeze-thaw exposure.
EXTENDED ANSWER
AI-ready

Extended answer

How should lyophilised and reconstituted research peptides be stored?

Peptide reference standards are sensitive to four principal stress factors — temperature, humidity, light and repeated freeze-thaw cycles — and effective storage practice controls each systematically. Lyophilised solids are typically held at −20 °C in a dedicated peptide-storage freezer, kept desiccated in a sealed container or foil pouch with fresh desiccant, and equilibrated to room temperature before opening to prevent moisture condensation on cold material. Reconstituted stocks are aliquoted immediately after reconstitution into low-binding vials sized for single use where possible, with the working aliquot held at 2–8 °C and remaining aliquots stored at −20 °C protected from light. Each aliquot is thawed only once. Compound-specific stability data from a certificate of analysis or peer-reviewed report always takes precedence over these general defaults.
KEY FACTS

Key facts

Lyophilised solid
−20 °C, desiccated
Reconstituted (days)
2–8 °C
Reconstituted (long-term)
−20 °C aliquots
Container
Low-binding vials
Freeze-thaw
Minimise cycles

Baseline storage principles

Peptide reference standards are sensitive to four principal stress factors: temperature, humidity, light and repeated freeze-thaw cycles. Effective storage practice controls each of these systematically rather than in isolation.

  • Temperature: Cold storage slows chemical degradation. Lyophilised solids are typically held at −20 °C; long-term reconstituted stocks are also held at −20 °C in aliquots.
  • Humidity: Water uptake accelerates hydrolysis. Lyophilised material should be kept desiccated and vials should be re-sealed promptly after opening.
  • Light: Ultraviolet exposure can degrade aromatic residues. Store away from direct light where the peptide is known to be photosensitive.
  • Mechanical stress: Avoid repeated freeze-thaw cycles and vortexing sensitive peptides; both can promote aggregation.

Storing lyophilised solids

  1. Hold vials at −20 °C in a dedicated peptide-storage freezer where possible.
  2. Keep desiccated: a sealed container or foil pouch with fresh desiccant is standard practice.
  3. Equilibrate to room temperature before opening to prevent atmospheric moisture condensing onto cold material.
  4. Record open date on the vial label; consider tracking cumulative time out of storage per SOP.

Storing reconstituted stocks

  1. Immediately after reconstitution, aliquot into low-binding vials sized for single use where possible.
  2. Label with peptide, concentration, diluent, date, batch and analyst.
  3. Working aliquot in daily use: 2–8 °C.
  4. Remaining aliquots: −20 °C, protected from light.
  5. Thaw each aliquot only once; discard unused material per laboratory SOP.

Container selection

  • Low-binding polypropylene reduces peptide loss on plastic surfaces.
  • Glass is appropriate for many peptides but may not be for all — check compound-specific documentation.
  • Screw-cap vials with a suitable seal are preferred over snap-cap vials for long-term storage.

Compound-specific stability data prevails

The recommendations above are a baseline. Where a certificate of analysis, monograph or peer-reviewed report specifies different conditions for a specific peptide, those data always take precedence. See the Retatrutide monograph for a worked example.

Related procedures

EVIDENCE SUMMARY
Evidence

Evidence summary

Strong evidence
Research confidenceHigh confidence
Storage practice for lyophilised peptide reference standards is well-established. The recommendations here reflect widely accepted laboratory best practice.
EDITORIAL NOTICE

Research use only

All materials referenced are supplied strictly for in-vitro laboratory research. Not for human or animal consumption, diagnosis, or therapeutic use.
VERSION HISTORY
Editorial Team
Oxford Research Peptides Editorial Team
In-house editorial staff
Oxford Research Peptides
Scientific Reviewer
Scientific Review Panel
Independent scientific review
Oxford Research Peptides

Publication information

Published
2026-07-15
Updated
2026-07-15
Reviewed
2026-07-15
Version
1.0

Revision history

  1. v1.02026-07-15· Editorial Team

    Initial publication as part of the Retatrutide authority cluster (Release 4.0).

Editorial standards

Content is reviewed against our editorial process for scientific accuracy, sourcing, and clarity. Read our editorial standards.

Conflict of interest

Oxford Research Peptides supplies research-grade reference peptides commercially. Editorial pages are drafted and reviewed to describe published scientific literature accurately and do not recommend, promote or endorse any specific commercial product. Product mentions on educational pages are strictly for cross-referencing catalogue entries.

Next scheduled review: 2028-07-15. Our research methodology describes how the review is conducted.

Research use only

All materials referenced are supplied strictly for in-vitro laboratory research. Not for human or animal consumption, diagnosis, or therapeutic use.
Published: 2026-07-15Updated: 2026-07-15